Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;139(1):107582.
doi: 10.1016/j.ymgme.2023.107582. Epub 2023 Apr 17.

Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects

Affiliations
Review

Clinical and biochemical footprints of inherited metabolic diseases. XII. Immunological defects

Lonneke de Boer et al. Mol Genet Metab. 2023 May.

Abstract

Immunological problems are increasingly acknowledged manifestations in many inherited metabolic diseases (IMDs), ranging from exaggerated inflammation, autoimmunity and abnormal cell counts to recurrent microbial infections. A subgroup of IMDs, the congenital disorders of glycosylation (CDG), includes CDG types that are even classified as primary immunodeficiencies. Here, we reviewed the list of metabolic disorders reported to be associated with various immunological defects and identified 171 IMDs accompanied by immunological manifestations. Most IMDs are accompanied by immune dysfunctions of which immunodeficiency and infections, innate immune defects, and autoimmunity are the most common abnormalities reported in 144/171 (84%), 44/171 (26%) and 33/171 (19%) of IMDs with immune system involvement, respectively, followed by autoinflammation 17/171 (10%). This article belongs to a series aiming at creating and maintaining a comprehensive list of clinical and metabolic differential diagnoses according to organ system involvement.

Keywords: Autoimmunity; Immune defect; Immunodeficiency; Inherited metabolic disorders.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Occurrence (%) of symptoms associated with disorders affecting immune system in 10 categories of IMDs. The percentages for immunological involvement were calculated using as the denominator the total number of IMDs in each category presenting with any phenotype. Heat scale ranges from red (0%) for diseases with no particular symptoms reported to violet (100%) for diseases with particular symptoms occurring with highly frequency within the disorders group. For definition of 4 categories of disorders with immune system involvement see Supplemental Table 1.

Similar articles

Cited by

References

    1. Angelini C, Burlina A, Blau N, Ferreira CR, Clinical and biochemical footprints of inherited metabolic disorders: X. Metabolic myopathies Mol Genet Metab 137 (2022) 213–222. - PMC - PubMed
    1. Bakhos D, Blasco H, Galvin JJ 3rd, Ferreira CR, Blau N, Clinical and biochemical footprints of inherited metabolic diseases. IX. Metabolic ear disease Mol Genet Metab 137 (2022) 223–229. - PMC - PubMed
    1. Ferreira CR, Blau N, Clinical and biochemical footprints of inherited metabolic diseases. IV. Metabolic cardiovascular disease Mol Genet Metab 132 (2021) 112–118. - PMC - PubMed
    1. Ferreira CR, Cassiman D, Blau N, Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases Mol Genet Metab 127 (2019) 117–121. - PMC - PubMed
    1. Ferreira CR, Hoffmann GF, Blau N, Clinical and biochemical footprints of inherited metabolic diseases. I. Movement disorders Mol Genet Metab 127 (2019) 28–30. - PMC - PubMed

Publication types